In vivo xenograft assays using BALB/c nude mice demonstrated that SLC16A3 knockdown markedly reduced tumor growth, as evidenced by the reduced tumor weight and volume over time (Figures 2F–H). This evidence concerns the gene SLC16A3 and neoplasm.